INSIGHTS ON QUALITY CONTROL
-
Contamination Control Strategy: Compressed Gas Monitoring Of Microbes
Microbial survival during gas decompression is a proven risk. Learn why point-of-use monitoring is essential for Annex 1 compliance and how to ensure process gas purity in sterile environments.
-
Pharmaceutical Labeling That Protects Product, Patient And Production
Modern pharmaceutical labeling systems streamline serialization, tamper-evident sealing, and vision inspection to reduce line risk and maintain regulatory compliance across all production scales.
-
Applying AI And Rapid Prototyping To Media And Process Development
Hear from industry experts on how teams can integrate manufacturability considerations earlier through rapid prototyping, data-driven media development, and predictive modeling.
-
An Overview Of 2026 Life Sciences Industry Trends
Explore the paradigm shift reshaping life sciences. Learn how connecting data streams across the product lifecycle drives predictive compliance and operational excellence.
-
Trend Analysis Of Particle Monitoring Data And Defining Alert And Action Limits9/9/2026
Routine trend analysis of total and viable particle monitoring data helps identify operational shifts early, set statistical limits, and strengthen cleanroom contamination control strategies.
-
Validating VH2O2 Decontamination Cycles For Product And Personnel Safety6/30/2026
Discover how ultra-sensitive spectroscopy transforms decontamination validation, revealing hidden efficiencies that safely cut facility downtime while ensuring absolute safety.
-
Integration Of Container Closure Integrity In Contract Manufacturing3/28/2025
Maintaining drug product sterility and compliance demands rigorous Container Closure Integrity (CCI) within contract manufacturing. Learn how to fortify your processes.
-
Minimizing Drug Product Loss In Manufacturing3/17/2026
Explore how optimized analytical testing, reduced material wastage, and advanced sterile fill-finish technologies can work together to preserve valuable GMP material without compromising quality.
-
Utilizing A Stepwise Approach For Nitrosamine Risk Mitigation5/15/2025
Insights and case studies demonstrate how a tailored, stepwise testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.
QUALITY CONTROL SOLUTIONS
-
Our solutions have been specified in the testing process for the top two GLP-1 manufacturers
-
Active bead release gives manufacturers precise control over T cell isolation timing, phenotype preservation, and workflow efficiency, eliminating multi-day passive dissociation delays.
-
Explore how specialized analytical expertise and advanced instrumentation enable precise nitrosamine testing to help drug developers meet strict and evolving regulatory requirements.
-
Pyrogen detection is one of the mandatory release tests for sterile parenteral drugs testing in the course of pharmaceutical quality control. Test methods being used are the rabbit pyrogen test (RPT), the bacterial endotoxin test (or LAL test), and the monocyte activation test (MAT).
-
The X2 and X6 Packaged X-ray Inspection Series enhance safety by detecting contaminants and improving product quality with advanced technologies, supporting productivity, compliance, and brand protection.